Skip to content
ChickenStockChickenStock
Research950260
Ingenia Therapeutics logo

Ingenia Therapeutics (950260) stock

KOSDAQ · Biotechnology

KRW 20,1000.00%(0)

As of Nov 16, 9:16 AM KST

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Latest fiscal year

Latest fiscal-year financials · Computed in-house by ChickenStock

P/E

—

P/B

75.17x

P/S

—

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
H1 2026Consolidated · Filed Aug 19, 2026KRW 6.7 billion-KRW 6.7 billion-KRW 6.1 billion—
  • Year-to-date rows are cumulative from the start of the fiscal year.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
8.37%
Of trading value on Nov 13, 2026
Short-sale value
KRW 420 million
Previous 20-day average 5.00%
Net short position
0 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
605,518 shares
As of Nov 13, 2026 · 1.22% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20268.37%KRW 420 million
Nov 12, 20266.17%KRW 360 million
Nov 11, 202611.22%KRW 370 million
Nov 10, 202615.06%KRW 850 million
Nov 9, 20264.64%KRW 350 million
Nov 6, 20264.22%KRW 220 million
Nov 5, 20261.29%KRW 80 million
Nov 4, 20262.22%KRW 170 million
Nov 3, 20261.85%KRW 80 million
Nov 2, 20266.69%KRW 180 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

Ingenia Therapeutics (950260) stock information

KOSDAQ

Ingenia Therapeutics (950260) is listed on KOSDAQ. Its market capitalization is about KRW 993.8 billion. These figures are computed in-house from official filings and are reference information only.

Ingenia Therapeutics — frequently asked questions

What is the market capitalization of Ingenia Therapeutics?
950260 has a market capitalization of about KRW 993.8 billion. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.